.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Novartis
McKesson
Harvard Business School
AstraZeneca
Baxter
Moodys
Chubb
Chinese Patent Office
US Department of Justice

Generated: September 21, 2017

DrugPatentWatch Database Preview

TRIFLURIDINE Drug Profile

« Back to Dashboard

Which patents cover Trifluridine, and when can generic versions of Trifluridine launch?

Trifluridine is a drug marketed by Sandoz Inc and Hi-tech Pharmacal and is included in two NDAs.

The generic ingredient in TRIFLURIDINE is trifluridine. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the trifluridine profile page.

Summary for Tradename: TRIFLURIDINE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list54
Clinical Trials: see list4
Patent Applications: see list3,682
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIFLURIDINE at DailyMed

Pharmacology for Tradename: TRIFLURIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
TRIFLURIDINE
trifluridine
SOLUTION/DROPS;OPHTHALMIC074311-001Oct 6, 1995ATRXNoNo► Subscribe► Subscribe► Subscribe
Hi-tech Pharmacal
TRIFLURIDINE
trifluridine
SOLUTION/DROPS;OPHTHALMIC205438-001Jul 28, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Express Scripts
QuintilesIMS
Healthtrust
Harvard Business School
AstraZeneca
Teva
Fish and Richardson
Mallinckrodt
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot